- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TerrAscend issued its financial report for the second quarter of 2018.
TerrAscend (CSE:TER) issued its financial report for the second quarter of 2018.
As quoted in the press release:
“TerrAscend continued to execute on its business plan as we prepare for the sale of adult-use cannabis in Canada” said Michael Nashat, TerrAscend’s President and Chief Executive Officer. “Our emphasis remains focused on investing in strategic assets and completing construction of the company’s flagship EU-GMP compliant facility in Ontario. It’s an exciting time at TerrAscend as we lay the groundwork for anticipated near-term sales growth with the long-term vision of becoming a leader in the global cannabinoid market.”
FINANCIAL HIGHLIGHTS
The Company incurred a net loss of C$5.2M or C$0.05 per share for the second quarter, compared with a net loss of C$3.5M or C$0.12 per share for the same period last year.
Capital expenditures were C$2.6M for the second quarter for the build out of the Company’s facility.
The company deployed C$11.2M in cash to further build inventory in preparation for adult use sales in October.
C$26.1M in cash and cash equivalents were held by the company at quarter end.
Click here to read the full press release.
Source: www.newswire.ca
Outlook Reports
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2191.55 | +12.11 | |
Silver | 24.58 | +0.15 | |
Copper | 3.99 | -0.02 | |
Oil | 81.10 | -0.52 | |
Heating Oil | 2.59 | -0.02 | |
Natural Gas | 1.72 | -0.07 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.